三星医疗：上半年净利12.30亿元，同比增6.93%

Core Insights - Samsung Medical reported a revenue of 7.972 billion yuan for the first half of 2025, representing a year-on-year growth of 13.93% [1] - The net profit attributable to shareholders for the same period was 1.230 billion yuan, showing a year-on-year increase of 6.93% [1] - The company plans to distribute a cash dividend of 4.85 yuan (including tax) for every 10 shares to its shareholders [1]